SynthesisHepatology international2023

Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.

Eui Gwon Hwang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.